Hyperbilirubinemia and Associated Factors Among Neonates Admitted to the Neonatal Care Unit in Jimma Medical Center.

Jimma Medical Centre Neonatal hyperbilirubinemia

Journal

Clinical medicine insights. Pediatrics
ISSN: 1179-5565
Titre abrégé: Clin Med Insights Pediatr
Pays: United States
ID NLM: 101595023

Informations de publication

Date de publication:
2023
Historique:
received: 27 10 2022
accepted: 25 07 2023
pubmed: 29 8 2023
medline: 29 8 2023
entrez: 29 8 2023
Statut: epublish

Résumé

Neonatal hyperbilirubinemia is a widespread and significant clinical problem among neonates worldwide. Globally, every year about 1.1 million babies develop it and the vast majority reside in South Asia and sub-Saharan Africa. Studies on the magnitude and factors associated with neonatal hyperbilirubinemia are limited in Ethiopia. So this study was aimed at assessing the prevalence and associated factors of neonatal hyperbilirubinemia among hospitalized neonates in the neonatal intensive care unit of Jimma Medical Center (JMC), Jimma, South West Ethiopia. Hospital-based cross-sectional study was conducted at JMC from July 24 to October 19, 2020. A total of 222 neonates with their mothers were included and conveniently selected. Data was collected by interviewing mothers through structured questionnaires and reviewing neonates' medical records using a checklist. Multivariable binary logistic regression analyses were employed to identify factors associated with neonatal hyperbilirubinemia. from a total of neo-maternal pairs included in the studies; the proportion of Neonatal hyperbilirubinemia was found to be 94 (42.3%). Neo-maternal ABO incompatibility 33 (35.1%), prematurity 41 (43.6%), sepsis 35 (37.2%), Neonatal birth asphyxia 20 (21.2%), and Rh isoimmunization 10 (10.6%) was significantly associated with neonatal hyperbilirubinemia. The prevalence of neonatal hyperbilirubinemia in the study setting was high. Antenatal care (including both mother and fetus detail examination and follow-ups) as well as cautions during labor need to focus on since Neonatal hyperbilirubinemia-associated factors were maternal and neonatal. Hence, further assessment, early intervention, and timely treatment are important to mitigate the burdens in neonates due to hyperbilirubinemia.

Sections du résumé

Background UNASSIGNED
Neonatal hyperbilirubinemia is a widespread and significant clinical problem among neonates worldwide. Globally, every year about 1.1 million babies develop it and the vast majority reside in South Asia and sub-Saharan Africa. Studies on the magnitude and factors associated with neonatal hyperbilirubinemia are limited in Ethiopia. So this study was aimed at assessing the prevalence and associated factors of neonatal hyperbilirubinemia among hospitalized neonates in the neonatal intensive care unit of Jimma Medical Center (JMC), Jimma, South West Ethiopia.
Design UNASSIGNED
Hospital-based cross-sectional study was conducted at JMC from July 24 to October 19, 2020.
Methods UNASSIGNED
A total of 222 neonates with their mothers were included and conveniently selected. Data was collected by interviewing mothers through structured questionnaires and reviewing neonates' medical records using a checklist. Multivariable binary logistic regression analyses were employed to identify factors associated with neonatal hyperbilirubinemia.
Results UNASSIGNED
from a total of neo-maternal pairs included in the studies; the proportion of Neonatal hyperbilirubinemia was found to be 94 (42.3%). Neo-maternal ABO incompatibility 33 (35.1%), prematurity 41 (43.6%), sepsis 35 (37.2%), Neonatal birth asphyxia 20 (21.2%), and Rh isoimmunization 10 (10.6%) was significantly associated with neonatal hyperbilirubinemia.
Conclusion UNASSIGNED
The prevalence of neonatal hyperbilirubinemia in the study setting was high. Antenatal care (including both mother and fetus detail examination and follow-ups) as well as cautions during labor need to focus on since Neonatal hyperbilirubinemia-associated factors were maternal and neonatal. Hence, further assessment, early intervention, and timely treatment are important to mitigate the burdens in neonates due to hyperbilirubinemia.

Identifiants

pubmed: 37641684
doi: 10.1177/11795565231193910
pii: 10.1177_11795565231193910
pmc: PMC10460632
doi:

Types de publication

Journal Article

Langues

eng

Pagination

11795565231193910

Informations de copyright

© The Author(s) 2023.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Sintayehu Asaye (S)

School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.

Misgana Bekele (M)

School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.

Aklilu Getachew (A)

School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.

Diriba Fufa (D)

Faculty of Medical Sciences, Jimma University, Jimma, Ethiopia.

Tesfaye Adugna (T)

Department of Biomedical Sciences, Jimma University, Jimma, Ethiopia.

Edosa Tadese (E)

School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.

Classifications MeSH